One telehealth consult and a doctor prescribed unapproved peptides

ABC News reports on a troubling regulatory gap in Australia's longevity market: telehealth clinics are prescribing unapproved peptide treatments with minimal oversight. The industry is exploiting these regulatory gaps, potentially exposing consumers to unvetted and risky medications.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton